Drug Trial Radar · NCT01703052
Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV)
Last checked: Nov 19, 2026Latest source record: Jul 31, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
74
Actual
Start
Jul 2011
Primary completion
May 2012
Study completion May 2012
Sponsor
- Lead sponsor
- Chiesi Farmaceutici S.p.A.Industry
- Sponsor type
- Industry
- First posted
- Oct 10, 2012
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is designed to investigate the safety, tolerability and pharmacokinetics of inhaled CHF 6001 after single and multiple doses in healthy volunteers.
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
Interventions
CHF 6001 SD or placeboDrug
Dry Powder Inhaler
CHF 6001 MD or placeboDrug
Dry Powder Inhaler
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse events, adverse drug reactions, serious adverse events.Time frame: After 7 days of treatment
- Vital signsTime frame: After 7 days of treatment
- 12-lead ECGTime frame: After 7 days of treatment
- 24h ECG HolterTime frame: After 7 days of treatment
- FEV1Time frame: After 7 days of treatment
- Blood and urine Laboratory testsTime frame: After 7 days of treatment
- Body weightTime frame: After 7 days of treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Quotient Clinical
Nottingham, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.